US Stock MarketDetailed Quotes

PEPG PepGen

Watchlist
  • 3.920
  • -0.360-8.41%
Close Dec 27 16:00 ET
  • 3.710
  • -0.210-5.36%
Post 20:01 ET
127.78MMarket Cap-1.32P/E (TTM)

About PepGen Company

PepGen Inc. develops oligonucleotide therapies. It is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The company was founded in March 26, 2018 and is headquartered in Boston, MA.

Company Profile

SymbolPEPG
Company NamePepGen
Listing DateMay 6, 2022
Issue Price12.00
Founded2018
CEOMr. James McArthur, PhD
MarketNASDAQ
Employees64
Fiscal Year Ends12-31
Address321 Harrison Avenue,8th Floor
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02118
Phone1-781-797-0979
Websitehttp://pepgen.com

Company Executives

  • Name
  • Position
  • Salary
  • James McArthur, PhD
  • President, Chief Executive Officer and Director
  • 3.43M
  • Noel Donnelly, M.B.A.
  • Chief Financial Officer and Principal Accounting Officer
  • 1.97M
  • Dr. Michelle L. Mellion, M.D.
  • Senior Vice President, Clinical Development
  • 1.41M
  • Dr. Niels Svenstrup, PhD
  • Senior Vice President, Chemistry, Manufacturing and Control
  • --
  • Laurie B. Keating, J.D.
  • Chairman of the Board
  • 154.82K
  • Heidi Henson, C.P.A.
  • Independent Director
  • 123.32K
  • Habib Joseph Dable
  • Independent Director
  • 90.24K
  • Dr. Howard Mayer, M.D.
  • Independent Director
  • 64.16K
  • Mary Beth DeLena, J.D.
  • General Counsel and Secretary
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data